Recurrent Metastatic Chordoma to the Liver: A Case Report and Review of the Literature

被引:4
作者
Dickerson, Thomas E. [1 ]
Ullah, Asad [2 ]
Saineni, Sathvik [1 ]
Sultan, Sandresh [3 ]
Sama, Srikar [1 ]
Ghleilib, Intisar [2 ]
Patel, Nikhil G. [2 ]
Elhelf, Islam A. [4 ]
Karim, Nagla Abdel [5 ]
机构
[1] Augusta Univ, Med Coll Georgia, Augusta, GA 30912 USA
[2] Augusta Univ, Dept Pathol, Augusta, GA 30912 USA
[3] Bolan Med Coll, Dept Med, Quetta 83700, Pakistan
[4] Augusta Univ, Dept Radiol, Augusta, GA 30912 USA
[5] Univ Virginia, Inova Schar Canc Inst, Fairfax, VA 22031 USA
关键词
malignant; chordoma; magnetic resonance imaging; SPINAL CHORDOMA; EGFR; MANAGEMENT; EXPRESSION;
D O I
10.3390/curroncol29070367
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Chordoma is a rare malignant neoplasm derived from notochordal tissue that primarily affects the axial skeleton. Almost 40% of patients have non-cranial chordoma metastases. The most common metastatic sites are the lungs, bones, lymph nodes, and subcutaneous tissue. We present a 52-year female with a history of sacral chordoma presenting with abdominal fullness, early satiety, and a palpable abdominal mass. Abdominal magnetic resonance imaging (MRI) revealed an isolated, highly vascularized, and multilobed liver mass in the left lateral segment. The mass was surgically removed using a clean surgical margin. A histological examination and immunohistochemical staining were consistent with a metastatic chordoma. Two years later, follow-up imaging studies showed a 6.5 x 4.0 x 2.0 cm right liver lesion with multiple lungs, chest wall, pleural, and diaphragmatic lesions. Microscopic- and immunohistochemical staining revealed a recurrent metastatic chordoma. Herein, we present a unique case of metastatic recurrent chordoma in the liver with the involvement of other sites. To the best of our knowledge, no other case of recurrent liver metastasis has been reported.
引用
收藏
页码:4625 / 4631
页数:7
相关论文
共 31 条
  • [1] Akhavan-Sigari R, 2014, ANTICANCER RES, V34, P623
  • [2] Analysis of the Infiltrative Features of Chordoma: The Relationship Between Micro-Skip Metastasis and Postoperative Outcomes
    Akiyama, Toru
    Ogura, Koichi
    Gokita, Tabu
    Tsukushi, Satoshi
    Iwata, Shintaro
    Nakamura, Tomoki
    Matsumine, Akihiko
    Yonemoto, Tsukasa
    Nishida, Yoshihiro
    Saita, Kazuo
    Kawai, Akira
    Matsumoto, Seiichi
    Yamaguchi, Takehiko
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2018, 25 (04) : 912 - 919
  • [3] Synergistic drug combinations and machine learning for drug repurposing in chordoma
    Anderson, Edward
    Havener, Tammy M.
    Zorn, Kimberley M.
    Foil, Daniel H.
    Lane, Thomas R.
    Capuzzi, Stephen J.
    Morris, Dave
    Hickey, Anthony J.
    Drewry, David H.
    Ekins, Sean
    [J]. SCIENTIFIC REPORTS, 2020, 10 (01)
  • [4] Targeting an EGFR Water Network with 4-Anilinoquin(az)oline Inhibitors for Chordoma
    Asquith, Christopher R. M.
    Maffuid, Kaitlyn A.
    Laitinen, Tuomo
    Torrice, Chad D.
    Tizzard, Graham J.
    Crona, Daniel J.
    Zuercher, William J.
    [J]. CHEMMEDCHEM, 2019, 14 (19) : 1693 - 1700
  • [5] MicroRNA expression profiling reveals the potential function of microRNA-31 in chordomas
    Bayrak, Omer Faruk
    Gulluoglu, Sukru
    Aydemir, Esra
    Ture, Ugur
    Acar, Hasan
    Atalay, Basar
    Demir, Zeynel
    Sevli, Serhat
    Creighton, Chad J.
    Ittmann, Michael
    Sahin, Fikrettin
    Ozen, Mustafa
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2013, 115 (02) : 143 - 151
  • [6] CHAMBERS PW, 1979, AM J CLIN PATHOL, V72, P765
  • [7] The Current Understanding of MicroRNA's Therapeutic, Diagnostic, and Prognostic Role in Chordomas: A Review of the Literature
    Choi, Paul J.
    Oskouian, Rod J.
    Tubbs, R. Shane
    [J]. CUREUS, 2018, 10 (12):
  • [8] Surgical management of chordoma: A systematic review
    Denaro, Luca
    Berton, Alessandra
    Ciuffreda, Mauro
    Loppini, Mattia
    Candela, Vincenzo
    Brandi, Maria Luisa
    Longo, Umile Giuseppe
    [J]. JOURNAL OF SPINAL CORD MEDICINE, 2020, 43 (06) : 797 - 812
  • [9] FLEMING GF, 1993, CANCER, V72, P714, DOI 10.1002/1097-0142(19930801)72:3<714::AID-CNCR2820720314>3.0.CO
  • [10] 2-1